Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein’s Labs
TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — Biosenta Inc. (“Biosenta” or the…
TORONTO and CALGARY, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — Biosenta Inc. (“Biosenta” or the…
TORONTO and HOUSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”)…
TORONTO and HOUSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”)…
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage…
FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage…
Phase 2 data from vebreltinib (APL-101), a highly selective cMet inhibitor, in patients with NSCLC…
Phase 2 data from vebreltinib (APL-101), a highly selective cMet inhibitor, in patients with NSCLC…
Data presented at the 2023 Special Meeting on Pancreatic Cancer of the American Association for…
Data presented at the 2023 Special Meeting on Pancreatic Cancer of the American Association for…
Presented preclinical proof-of-concept data for new, wholly owned program targeting INHBE for metabolic disorders, including…
AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,”…
AI-driven literature extraction for thousands of rare disease genes fortifies and extends QIAGEN’s proprietary, human-certified…
TARRYTOWN, N.Y., Sept. 28, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced…
PALO ALTO, Calif.–(BUSINESS WIRE)–Nexusflow, a Generative AI leader targeting the cybersecurity industry, announced today that…
BOSTON, Sept. 28, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an…
CONSHOHOCKEN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a clinical-stage…
CHATHAM, N.J., Sept. 28, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix”…
Cash and cash equivalents at €31.2 million, short-term deposits at €0.05 million1, and long-term deposit…
New Kit expands suite of NGS Library Prep solutions on the BioXp® System Enabling Speed…
ProvisionAI Chosen as Top Three Finalist in CSCMP 3Vs Innovation Awards FRANKLIN, Tenn., Sept. 28,…